| Title |
Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications
|
|---|---|
| Published in |
BMC Medicine, September 2006
|
| DOI | 10.1186/1741-7015-4-22 |
| Pubmed ID | |
| Authors |
Sonia Hernández-Díaz, Luis A García Rodríguez |
| Abstract |
To balance the cardiovascular benefits from low-dose aspirin against the gastrointestinal harm caused, studies have considered the coronary heart disease risk for each individual but not their gastrointestinal risk profile. We characterized the gastrointestinal risk profile of low-dose aspirin users in real clinical practice, and estimated the excess risk of upper gastrointestinal complications attributable to aspirin among patients with different gastrointestinal risk profiles. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 20% |
| United Kingdom | 1 | 20% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 3 | 60% |
| Science communicators (journalists, bloggers, editors) | 1 | 20% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 1% |
| Malaysia | 1 | 1% |
| India | 1 | 1% |
| Canada | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 84 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 21% |
| Student > Ph. D. Student | 12 | 13% |
| Other | 9 | 10% |
| Professor > Associate Professor | 9 | 10% |
| Student > Bachelor | 9 | 10% |
| Other | 20 | 22% |
| Unknown | 11 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 49% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 9% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Agricultural and Biological Sciences | 3 | 3% |
| Economics, Econometrics and Finance | 2 | 2% |
| Other | 9 | 10% |
| Unknown | 18 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2016.
All research outputs
#6,031,464
of 22,761,738 outputs
Outputs from BMC Medicine
#2,309
of 3,413 outputs
Outputs of similar age
#20,472
of 67,549 outputs
Outputs of similar age from BMC Medicine
#5
of 5 outputs
Altmetric has tracked 22,761,738 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,413 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.5. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,549 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one.